Asian Conference on Hepatitis and AIDS (ACHA) 2018

Living donor liver transplantation for hepatitis virus related liver diseases- Chao-Long Chen, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Prevention of recurrent hepatitis B after liver transplantation- Chung Mau Lo, BBS, JP, MBBS, MS, FRCS, FRACS, FACS, FHKAM (Surgery), FCSHK

Slideset

HIV

Viral Hepatitis and Liver Disease

Elimination of viral hepatitis: Global perspective- Zhongdan Chen, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Treatment of CHB in China: Experience and evidence from real-world studies- Jidong Jia, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Non-viral liver diseases in China- Zhongping Duan, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

CHB treatment with Chinese medicine and NAs- Yongping Yang, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

CHB treatment with Chinese medicine and NAs- Yongping Yang, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Efficacy and tolerability of grazoprevir and elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV and HIV co-infection: A nonrandomised, open-label clinical trial- Chien-Yu Cheng

Slideset

HIV

Viral Hepatitis and Liver Disease

HIV-1/HCV co-infection treatment with single-tablet antiviral regimens (CoSTARs): 12 Weeks of Ledipasvir/ Sofosbuvir (LDV/SOF) after randomized switch to Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir alafenamide (E/C/F/TAF) or rilpivirin- Damian Mccoll

Slideset

HIV

Viral Hepatitis and Liver Disease

New indicators for the evaluation of hepatitis B therapy- Xinxin Zhang, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Sequential cross-section study on hepatitis viruses infection in Chinese AIDS patients- Lin Liu, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Asian Conference on Hepatitis and AIDS (ACHA) 2018

Reaching 90-90-90 and beyond- Kees Brinkman, MD, PhD

Reaching 90-90-90 and beyond- Kees Brinkman, MD, PhD

Eradication of HIV- Bonaventura Clotet, MD, PhD

05_Chen_CN

Eradication of HIV- Bonaventura Clotet, MD, PhD

Living donor liver transplantation for hepatitis virus related liver diseases- Chao-Long Chen, MD, PhD

Prevention of recurrent hepatitis B after liver transplantation- Chung Mau Lo, BBS, JP, MBBS, MS, FRCS, FRACS, FACS, FHKAM (Surgery), FCSHK

Elimination of viral hepatitis: Global perspective- Zhongdan Chen, PhD

Treatment of CHB in China: Experience and evidence from real-world studies- Jidong Jia, MD, PhD

Non-viral liver diseases in China- Zhongping Duan, MD, PhD

CHB treatment with Chinese medicine and NAs- Yongping Yang, MD

CHB treatment with Chinese medicine and NAs- Yongping Yang, MD

Efficacy and tolerability of grazoprevir and elbasvir in peginterferon alfa plus ribavirin experienced patients with chronic genotype 1 HCV and HIV co-infection: A nonrandomised, open-label clinical trial- Chien-Yu Cheng

HIV-1/HCV co-infection treatment with single-tablet antiviral regimens (CoSTARs): 12 Weeks of Ledipasvir/ Sofosbuvir (LDV/SOF) after randomized switch to Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir alafenamide (E/C/F/TAF) or rilpivirin- Damian Mccoll

New indicators for the evaluation of hepatitis B therapy- Xinxin Zhang, MD, PhD

Sequential cross-section study on hepatitis viruses infection in Chinese AIDS patients- Lin Liu, MD

Non-alcoholic fatty liver disease in China- Jiangao Fan, MD, PhD